Regenovue Deep Plus Lidocaine 1,1ml (1 syringe x 1,1ml)

Regenovue Deep Plus Lidocaine 1.1ml (1 syringe x 1.1ml)

Regenovue Deep Plus Lidocaine is a high-quality dermal filler designed to address moderate to deep facial wrinkles and folds, as well as enhance facial contours. Formulated with cross-linked hyaluronic acid and lidocaine, it ensures effective results with minimal discomfort during the procedure.

Product Features

• High-Quality Hyaluronic Acid: Contains 24mg/ml of non-animal based, cross-linked hyaluronic acid, ensuring biocompatibility and longevity of results.
• Incorporated Lidocaine: Includes 0.3% lidocaine to minimize pain and enhance patient comfort during treatment.
• Monophasic Structure: Features a homogeneous gel with consistent particle size, providing stability and precise application for facial contouring.
• Low Endotoxin Level: Boasts an endotoxin level of less than 0.1EU/g, ensuring a high safety profile.
• Long-Lasting Effects: Results typically last between 12 to 18 months, depending on individual factors and treatment areas.

Indications

Regenovue Deep Plus Lidocaine is suitable for:

• Correction of moderate to deep wrinkles and folds, such as nasolabial folds and marionette lines.
• Enhancement of facial contours, including cheeks, chin, and jawline.
• Lip augmentation and definition.
• Improvement of perioral lines and forehead creases.

Technical Specifications

• Hyaluronic Acid Concentration: 24mg/ml
• Lidocaine Concentration: 0.3%
• Injection Depth: Lower dermis to upper subcutaneous layer
• Needle Size: 27G
• Duration of Effect: Approximately 12 to 18 months
• Storage Temperature: 2–25°C
• Shelf Life: 24 months
• CE Certification: Yes

Package Contents

Each package includes:

• 1 pre-filled syringe containing 1.1ml of Regenovue Deep Plus Lidocaine
• 2 sterile 27G needles
• Package insert with detailed instructions
• Traceability labels

Usage Instructions

Regenovue Deep Plus Lidocaine should be administered by licensed medical professionals trained in dermal filler injections. The product is injected into the lower dermis or upper subcutaneous layer using appropriate techniques for the treatment area. Injection sites should be determined based on individual patient needs and desired outcomes.

Safety Information

Common side effects may include temporary redness, swelling, or bruising at the injection sites, typically resolving within a few days. This product is contraindicated for individuals with known hypersensitivity to hyaluronic acid, lidocaine, or amide-type local anesthetics, those with active skin infections, and pregnant or breastfeeding women. Proper aseptic techniques must be followed to minimize the risk of infection.

Manufacturer Details

Brand: Regenovue

Manufacturer: NeoGenesis Co., Ltd.

Country of Origin: South Korea

Certification: CE-marked medical device